Literature DB >> 2551732

Isolation from human cerebrospinal fluid of a new insulin-like growth factor-binding protein with a selective affinity for IGF-II.

M Roghani1, P Hossenlopp, P Lepage, A Balland, M Binoux.   

Abstract

In biological fluids IGF-I and IGF-II are bound to specific, high-affinity binding protein (BPs). Two human BPs have been isolated, one from serum, which is GH-dependent, the other from amniotic fluid (AF BP), and their cDNAs have recently been cloned. We report here the isolation of another, new species from cerebrospinal fluid (CSF) where this BP predominates. The protein was purified to homogeneity by a four-step procedure: gel filtration, chromatofocusing, hydrophobic-interaction chromatography and reverse-phase chromatography. Thereafter, SDS-polyacrylamide gel electrophoresis gave an Mr of 34,000 (non-reduced), chromatofocusing gave an isoelectric point of 5.0m and its affinity for IGF-II (3 x 10(10) M-1) was 10 times that for IGF-I. The N-terminal amino acid sequence of the first 15 residues determined in a BP preparation from the CSF of children was Leu-Ala-Pro-Gly-(/)-Gly-Gln-Gly-Val-Gln-Ala-Gly-Ala-Pro-Gly. A similar sequence was found for adult CSF, apart from residues 12 and 13 (-Leu-Leu-). These are highly analogous with the sequences starting from residue 69 of the GH-dependent BP, and from residue 61 of the AF BP. The new BP isolated is therefore related to, but distinct from, the other human BPs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551732     DOI: 10.1016/0014-5793(89)81101-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  The insulin-like growth factor family of ligands, receptors, and binding proteins.

Authors:  R F Krywicki; D Yee
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.

Authors:  Y Oh; M W Beukers; H M Pham; P A Smanik; M C Smith; R G Rosenfeld
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

3.  Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells.

Authors:  S L Abboud; C R Bethel; D C Aron
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

4.  The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma.

Authors:  Y Gong; L Cui; G Y Minuk
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

5.  Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness.

Authors:  Ann-Christin Sandberg Nordqvist; Tiit Mathiesen
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

6.  Insulin-like growth factor (IGF)-I, -II and IGF-binding proteins in the cyst fluid of a patient with astrocytoma.

Authors:  W Zumkeller; M Sääf; T Rähn
Journal:  Childs Nerv Syst       Date:  1993-04       Impact factor: 1.475

7.  Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells.

Authors:  T Yamauchi; F Umeda; M Masakado; M Isaji; S Mizushima; H Nawata
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

8.  Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts.

Authors:  Lucia Micutkova; Thomas Diener; Chen Li; Adelina Rogowska-Wrzesinska; Christoph Mueck; Eveline Huetter; Birgit Weinberger; Beatrix Grubeck-Loebenstein; Peter Roepstorff; Rong Zeng; Pidder Jansen-Duerr
Journal:  Mech Ageing Dev       Date:  2011-07-24       Impact factor: 5.432

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.